Sharon Castellino MD, MSc, is Professor of Pediatrics at Emory University School of Medicine. Dr. Castellino serves as the Director of the Leukemia and Lymphoma Program at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, where she holds the Mark R. Hudgens Chair for Clinical Research. She is the founder and co-leader of the leukemia and lymphoma biorepository and vice chair for the pediatric oncology precision medicine protocol at Children's, and is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute at Emory University. Nationally, Dr. Castellino serves as the scientific chair for the Children's Oncology Group (COG) Hodgkin Lymphoma Committee. She has led several seminal clinical trials for children, adolescents, and young adults with Hodgkin lymphoma and has been a leader in creating models for collaborative research to benefit children and adolescents. Her expertise is in the study of outcomes and late effects in patients with hematologic malignancies and in the design of clinical trials in pediatric oncology. Her work across clinical trials, outcomes, and health services research has always included a focus in examining disparities in cancer outcomes by race, ethnicity, and age. Dr. Castellino received her undergraduate degree in Biochemistry at Mount Holyoke College and her MD from Duke University School of Medicine. She did her pediatric internship and second year of residency at Boston Children's Hospital and returned to Duke to complete her fellowship in pediatric Hematology and Oncology. She later obtained a master's degree in health outcomes at Wake Forest School of Medicine, where she founded and ran the pediatric cancer survivorship program.
